Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002040705-25-000002
Filing Date
2025-12-09
Accepted
2025-12-09 16:11:01
Documents
1
Period of Report
2025-12-06

Document Format Files

Seq Description Document Type Size
1 form4-12092025_091258.html 4  
1 form4-12092025_091258.xml 4 3368
  Complete submission text file 0002040705-25-000002.txt   4824
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 350 BAY STREET, SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address
DeLucia David (Reporting) CIK: 0002040705 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36740 | Film No.: 251559184